Literature DB >> 3717811

Glucagon reversal of hypotension in a case of anaphylactoid shock.

G P Zaloga, W DeLacey, E Holmboe, B Chernow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3717811     DOI: 10.7326/0003-4819-105-1-65

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  15 in total

Review 1.  Antivenom therapy in the Americas.

Authors:  K Heard; G F O'Malley; R C Dart
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 2.  Allergic emergencies in the emergency room.

Authors:  F Staikowsky; C Zanker; L Casenove
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 3.  Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?

Authors:  David M Lang
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

Review 4.  Perioperative anaphylaxis: pathophysiology, clinical presentation and management.

Authors:  P Dewachter; L Savic
Journal:  BJA Educ       Date:  2019-08-29

Review 5.  The risk and management of anaphylaxis in the setting of immunotherapy.

Authors:  Phil Lieberman
Journal:  Am J Rhinol Allergy       Date:  2012 Nov-Dec       Impact factor: 2.467

Review 6.  Critical care pharmacotherapy. A review.

Authors:  M Tryba; P J Kulka
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

7.  Acute renal failure associated with a labetalol overdose.

Authors:  A Korzets; P Danby; M E Edmunds; J Feehally; J Walls
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

8.  Navigating the updated anaphylaxis parameters.

Authors:  Stephen F Kemp
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

Review 9.  Beta-blocker therapy and the risk of anaphylaxis.

Authors:  J H Toogood
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

Review 10.  Anaphylactoid and anaphylactic reactions. Hazards of beta-blockers.

Authors:  D M Lang
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.